Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taku Fujimura

Showing results (211-220 of 283) with videos related to

Pageof 29
Sort By:
Melanoma Research|July 14, 2020
Increased serum CCL26 level is a potential biomarker for the effectiveness of anti-PD1 antibodies in patients with advanced melanomaTaku Fujimura, Kayo Tanita, Kentaro Ohuchi, et al.
The Journal of Dermatology|March 1, 2018
HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapyTaku Fujimura, Yumi Kambayashi, Kayo Tanita, et al.
Experimental Dermatology|September 28, 2022
Plasminogen activating inhibitor-1 promotes angiogenesis in cutaneous angiosarcomasKentaro Ohuchi, Ryo Amagai, Tetsuya Ikawa, et al.
Case Reports in Oncology|February 17, 2017
Successful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by DenosumabSadanori Furudate, Taku Fujimura, Akira Tsukada, et al.
Acta Dermato-Venereologica|February 12, 2014
Successful treatment of adult onset Langerhans cell histiocytosis with bi-weekly administration of pegylated interferon-αSadanori Furudate, Taku Fujimura, Yumi Kambayashi, et al.
Experimental Dermatology|April 20, 2019
Malassezia-derived aryl hydrocarbon receptor ligands enhance the CCL20/Th17/soluble CD163 pathogenic axis in extra-mammary Paget's diseaseYota Sato, Taku Fujimura, Kayo Tanita, et al.
Anticancer Research|April 5, 2017
Retrospective Investigation of Cutaneous Squamous Cell Carcinoma on the Lip Treated with Peplomycin Administered Through a Superficial Temporal ArteryTaku Fujimura, Kazuhiro Takahashi, Yumi Kambayashi, et al.
The Journal of Dermatology|December 4, 2016
Successful treatment of multiple in-transit melanomas on the leg with intensity-modulated radiotherapy and immune checkpoint inhibitors: Report of two casesTaku Fujimura, Yumi Kambayashi, Sadanori Furudate, et al.
The Journal of Dermatology|August 7, 2025
Diffuse Large B-Cell Lymphoma Arising in Mycosis Fungoides With Large-Cell TransformationEmi Yamazaki, Taku Fujimura, Yumi Kambayashi, et al.
Case Reports in Oncology|June 9, 2020
IL-23 Expression in Stewart-Treves Syndrome: Two Case Reports and Immunohistochemical InvestigationSaaya Yoshida, Taku Fujimura, Kentaro Ohuchi, et al.
Pageof 29

Showing results (211-220 of 283) with videos related to

Sort By:
Pageof 29
Melanoma Research|July 14, 2020
Increased serum CCL26 level is a potential biomarker for the effectiveness of anti-PD1 antibodies in patients with advanced melanomaTaku Fujimura, Kayo Tanita, Kentaro Ohuchi, et al.
The Journal of Dermatology|March 1, 2018
HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapyTaku Fujimura, Yumi Kambayashi, Kayo Tanita, et al.
Experimental Dermatology|September 28, 2022
Plasminogen activating inhibitor-1 promotes angiogenesis in cutaneous angiosarcomasKentaro Ohuchi, Ryo Amagai, Tetsuya Ikawa, et al.
Case Reports in Oncology|February 17, 2017
Successful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by DenosumabSadanori Furudate, Taku Fujimura, Akira Tsukada, et al.
Acta Dermato-Venereologica|February 12, 2014
Successful treatment of adult onset Langerhans cell histiocytosis with bi-weekly administration of pegylated interferon-αSadanori Furudate, Taku Fujimura, Yumi Kambayashi, et al.
Experimental Dermatology|April 20, 2019
Malassezia-derived aryl hydrocarbon receptor ligands enhance the CCL20/Th17/soluble CD163 pathogenic axis in extra-mammary Paget's diseaseYota Sato, Taku Fujimura, Kayo Tanita, et al.
Anticancer Research|April 5, 2017
Retrospective Investigation of Cutaneous Squamous Cell Carcinoma on the Lip Treated with Peplomycin Administered Through a Superficial Temporal ArteryTaku Fujimura, Kazuhiro Takahashi, Yumi Kambayashi, et al.
The Journal of Dermatology|December 4, 2016
Successful treatment of multiple in-transit melanomas on the leg with intensity-modulated radiotherapy and immune checkpoint inhibitors: Report of two casesTaku Fujimura, Yumi Kambayashi, Sadanori Furudate, et al.
The Journal of Dermatology|August 7, 2025
Diffuse Large B-Cell Lymphoma Arising in Mycosis Fungoides With Large-Cell TransformationEmi Yamazaki, Taku Fujimura, Yumi Kambayashi, et al.
Case Reports in Oncology|June 9, 2020
IL-23 Expression in Stewart-Treves Syndrome: Two Case Reports and Immunohistochemical InvestigationSaaya Yoshida, Taku Fujimura, Kentaro Ohuchi, et al.
Pageof 29